169 related articles for article (PubMed ID: 15162986)
1. Bone scan demonstrating metastasis to the breast from an ovarian carcinoma and a review of the literature.
Barai S; Kumar R; Haloi AK; Dhanpati ; Banopadhyaya G; Malhotra A
Clin Nucl Med; 2004 Mar; 29(3):167-70. PubMed ID: 15162986
[TBL] [Abstract][Full Text] [Related]
2. Concentration of Tc-99m MDP in ovarian carcinoma and its soft tissue metastases.
Beres RA; Patel N; Krasnow AZ; Isitman AT; Hellman RS; Veluvolu P; Patillo RS; Collier BD
Clin Nucl Med; 1991 Aug; 16(8):550-2. PubMed ID: 1934805
[TBL] [Abstract][Full Text] [Related]
3. Meningioma detected incidentally on early Tc-99m MDP whole-body imaging during a workup for breast cancer.
Cheng TF; Chen YK; Kao CH
Clin Nucl Med; 2005 Jan; 30(1):37-8. PubMed ID: 15604969
[No Abstract] [Full Text] [Related]
4. Incidental Detection of Ovarian Thecoma by 99mTc-MDP Whole-Body Bone Scan: Contribution of Hybrid SPECT/CT.
Zhang L; He Q; Zhou T; Zhang R
Clin Nucl Med; 2019 Oct; 44(10):e577-e578. PubMed ID: 31246684
[TBL] [Abstract][Full Text] [Related]
5. [Whole-body bone scintigraphy in the diagnosis and follow-up of the evolution of breast cancer].
Muşat E; Stefănescu C; Rusu V
Rev Med Chir Soc Med Nat Iasi; 1999; 103(1-2):163-9. PubMed ID: 10756905
[TBL] [Abstract][Full Text] [Related]
6. Fusion lymphoscintigraphy with a 24-hour Tc-99m MDP bone scan for sentinel lymph node detection and imaging.
Tatini VR; Dworkin HJ
Clin Nucl Med; 2001 Jan; 26(1):53. PubMed ID: 11139054
[TBL] [Abstract][Full Text] [Related]
7. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
[TBL] [Abstract][Full Text] [Related]
8. Bone metastasis versus bone marrow metastasis? Integration of diagnosis by (18)F-fluorodeoxyglucose positron emission/computed tomography in advanced malignancy with super bone scan: two case reports and literature review.
Lin CY; Chen YW; Chang CC; Yang WC; Huang CJ; Hou MF
Kaohsiung J Med Sci; 2013 Apr; 29(4):229-33. PubMed ID: 23541269
[TBL] [Abstract][Full Text] [Related]
9. Appearances of soft tissue calcification on Tc99m MDP bone scan.
Majeed Y; Riaz S; Hassan A
J Pak Med Assoc; 2019 Apr; 69(4):600. PubMed ID: 31000873
[TBL] [Abstract][Full Text] [Related]
10. Incidental thyroid Tc-99m methylene diphosphonate (MDP) uptake in a patient affected by polynodular goiter at bone scintigraphy.
Bertagna F; Bosio G; Giubbini R
Nucl Med Rev Cent East Eur; 2009; 12(2):81-2. PubMed ID: 20235059
[TBL] [Abstract][Full Text] [Related]
11. Severe systemic reaction to (99m)Tc-methylene diphosphonate: a case report.
Balan KK; Choudhary AK; Balan A; Wishart G
J Nucl Med Technol; 2003 Jun; 31(2):76-8. PubMed ID: 12777457
[TBL] [Abstract][Full Text] [Related]
12. Visualization of fatal hepatic necrosis on bone scan.
Hosono M; Machida K; Honda N; Takahashi T; Ohtawa N
Clin Nucl Med; 2003 May; 28(5):398-9. PubMed ID: 12702937
[No Abstract] [Full Text] [Related]
13. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer.
Hsia TC; Shen YY; Yen RF; Kao CH; Changlai SP
Neoplasma; 2002; 49(4):267-71. PubMed ID: 12382027
[TBL] [Abstract][Full Text] [Related]
14. Metastatic ovarian carcinoma showing surprisingly widespread subcutaneous 99mTc-MDP soft-tissue uptake.
Sogbein OO; Pelletier-Galarneau M; Pham XH
Clin Nucl Med; 2013 Oct; 38(10):812-4. PubMed ID: 24107812
[TBL] [Abstract][Full Text] [Related]
15. Technetium-99m diphosphonate imaging of psammocarcinoma of probable ovarian origin: case report and literature review.
Radin AI; Youssef IM; Quimbo RD; Perone RW; Guerrieri C; Abdel-Dayem HM
Clin Nucl Med; 2005 Jun; 30(6):395-9. PubMed ID: 15891291
[TBL] [Abstract][Full Text] [Related]
16. The value of whole body bone scan in the pre-operative assessment in carcinoma of the breast.
Hahn P; Vikterlöf KJ; Rydman H; Beckman KW; Blom O
Eur J Nucl Med; 1979 Jun; 4(3):207-10. PubMed ID: 115691
[TBL] [Abstract][Full Text] [Related]
17. Comparing whole body (18)F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer.
Yang SN; Liang JA; Lin FJ; Kao CH; Lin CC; Lee CC
J Cancer Res Clin Oncol; 2002 Jun; 128(6):325-8. PubMed ID: 12073051
[TBL] [Abstract][Full Text] [Related]
18. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by
Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W
Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of large bladder diverticulum on bone scan.
Chang CP; Tsai CH; Chen JH; Sheu MH; Hsieh HJ; Chang WD; Liao SQ; Liu RS
Clin Nucl Med; 2005 Apr; 30(4):276-7. PubMed ID: 15764891
[TBL] [Abstract][Full Text] [Related]
20. Scintigraphic visualization of traumatic leptomeningeal cyst on bone scan.
Ceylan E; Bozkurt MF; Caner B
Clin Nucl Med; 2003 Mar; 28(3):245-6. PubMed ID: 12592143
[No Abstract] [Full Text] [Related]
[Next] [New Search]
